Contact

Cervical Cancer Screening Device for the Developing World

Though highly treatable, cervical cancer is the third most common cancer worldwide and is often fatal, with 80% of cases occurring in the developing world. This is due in part to a lack of effective screening programs.

Access to life-saving screenings is impeded for many women in developing countries by their remote location, lack of qualified screeners, and social stigma. 

A team of researchers from the University of Pennsylvania worked with Smithwise to develop a low-cost cervical cancer screening device that can be used by a patient to capture images of her cervix for professional evaluation offsite. 

Penn_Logo_800w

 

Self-Cerv-for-GIF-no-insertion

medtech_mindset_global_subscribe_site_logo_brain

Subscribe to MedTech Mindset!

Receive the latest industry insights, news, podcasts, videos, and events for the medtech audience from your friends at Smithwise + Catapult (average 2 emails monthly).

MedTech Leaders Trust Smithwise + Catapult